Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models [Yahoo! Finance]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
TheFly reported on April 16 that Guggenheim Securities increased its price target on INSM from $227 to $230 while maintaining a Buy rating. The adjustment was made within a broader first-quarter earnings preview covering commercial-stage biotechnology companies. The firm updated its financial assumptions across the coverage group as part of its model revisions ahead of upcoming quarterly results. Separately, earlier on April 14, RBC Capital Markets increased its price target on Insmed Incorporated (NASDAQ:INSM) from $212 to $216 while maintaining an Outperform rating. The update incorporated findings from a physician survey assessing early real-world experience with Brinsupri and expectations for future prescribing behavior. Responses indicated favorable perceptions of the drug's clinical profile and a willingness among physicians to increase its use over time. The research also suggested that the population of patients considered eligible for treatment may expand significantly, su
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE Developments [Yahoo! Finance]Yahoo! Finance
- Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026PR Newswire
- Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm. They now have a $212.00 price target on the stock.MarketBeat
- Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim.MarketBeat
- Insmed (INSM) had its "outperform" rating reaffirmed by Royal Bank Of Canada.MarketBeat
INSM
Earnings
- 2/19/26 - Miss
INSM
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 144
- 4/8/26 - Form 4
- INSM's page on the SEC website